Modern Diagnostic IPO
Modern Diagnostic IPO Listing Day Performance
Modern Diagnostic listed on BSE SME on 07 January 2026 at ₹99.50, a 10.56% premium over the issue price of ₹90. A retail investor allotted the minimum application of 3,200 shares (2 lots) gained ₹30,400 at the listing price.
Demand going into listing
| Subscribed overall | 376.97× |
| QIB | 193.51× |
| NII | 702.43× |
| Retail | 342.46× |
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Financial Analysis
Financial Data
Financial Performance
| Metric | 2023 | 2024 | 2025 | June 2025 |
|---|---|---|---|---|
| Revenue | 56.61 | 68.67 | 78.80 | 22.67 |
| Expense | 62.55 | 61.81 | 66.08 | 18.40 |
| Profit (PAT) | 5.73 | 5.79 | 8.97 | 3.00 |
| Total Assets | 36.54 | 49.49 | 64.57 | 77.86 |
Peer Comparison
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Vijaya Diagnostic Centre Limited | 13.92 | 72.36 | 18 |
Promoters & Holding Pattern
Promoters: Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,10,00,000 | 99.99% |
| Promoter Holding Post Issue | 1,50,99,200 | 72.85% |
Strengths & Risks
- Heavily oversubscribed — 377.0x overall (final).
- Strong institutional (QIB) demand — 193.5x.
- Solid profit margin — 11.4%.
- Strong return on equity — 55%.
- Elevated leverage — debt/equity of 1.07.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
From this issue's live data. Not investment advice — read the RHP.
Company Information
Modern Diagnostic at a glance
From the company's description: “Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India.”
Modern Diagnostic is raising ₹37 crore through an IPO on the BSE SME. All of it is a fresh issue: there is no offer for sale, so every rupee raised goes to the company rather than to selling shareholders. Main stated uses of the fresh money: Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (₹20.69 crore), Funding Working Capital Requirement (₹11.6 crore) and Repayment of certain outstanding borrowings availed by the Company (₹4.5 crore).
Revenue went from ₹56.61 crore in 2023 to ₹78.8 crore in 2025, up 39% over 2 years. Profit after tax went from ₹5.73 crore to ₹8.97 crore, a net margin of 11% in the latest year.
The promoters, led by Mr. Devendra Singh Yadav, hold 100% before the issue and 73% after it — a dilution of 27.1 percentage points. Debt stands at 1.07 times equity.
Written from the issue's offer-document figures shown on this page. Not investment advice.
Company Contact Information
Modern Diagnostic & Research Centre Limited., Plot No H-64,1st Floor BLK-H, Bali, Nagar City landmark near Khetar Pal, Hospital, Ramesh Nagar, West Delhi,, New Delhi, Delhi-110015, India, Email Id: [email protected]
Objects of the Issue
| Purpose | Amount (Cr) |
|---|---|
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | 20.69 |
| Funding Working Capital Requirement | 11.60 |
| Repayment of certain outstanding borrowings availed by the Company | 4.50 |
| General Corporate Purpose | - |
Resources & Documents
Anchor Investors
Modern Diagnostic IPO - Quick Take
Modern Diagnostic has set a price band of Rs 85–Rs 90 per share for an issue size of Rs 37 crore. The stock listed with a 10.56% gain versus its issue price on January 07, 2026.
The issue is promoted by Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh with Beeline Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (Rs 21 crore) and funding Working Capital Requirement (Rs 12 crore).
On fundamentals, the company is posting revenue growth of 14.8%, a profit margin of 11.4%, return on equity of 55.2% in its most recent reported period. Listed peers in this segment include Vijaya Diagnostic Centre Limited (P/E 72.36x, market cap Rs 18 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Modern Diagnostic IPO: Lead Manager & Registrar Track Record
How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out Modern Diagnostic itself, so they describe what came before it.
- Modern Diagnostic listed at +10.6% on day one; the median of 193 listings was +1.5% (better than 70% of them).
- Subscribed 377x against a median of 3.98x across 192 issues (higher than 96%).
- Average listing-day move across all 194 SME listings we track: +11.6%.
| Firm | Other IPOs | Listed at / above issue | Avg move | Median |
|---|---|---|---|---|
| Beeline Capital Advisors Pvt. Ltd. Lead manager | 4 2 MB · 2 SME | 100% 4 of 4 | +13% | +4.3% |
| MUFG Intime India Pvt. Ltd. Registrar | 66 45 MB · 21 SME | 74% 46 of 62 | Check allotment → | |
Recent listings managed by Beeline Capital Advisors Pvt. Ltd. (4)
Best: Kratikal Tech +42.2% · Weakest: Vectras Enprocon +1%
| IPO | Listed | Listing-day move |
|---|---|---|
| Vectras Enprocon | 06 Nov 2026 | +1% |
| Shah Investor's | 06 Oct 2026 | +2.4% |
| Kratikal Tech | 07 Jul 2026 | +42.2% |
| Om Power Transmission | 17 Apr 2026 | +6.3% |
A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.
Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.
Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.
Frequently Asked Questions
Modern Diagnostic IPO GMP — What It Means
Its last GMP before listing was 15.6%. Of the 26 SME IPOs we have tracked with a final GMP between 10% and 25%, 21 listed above, 3 flat and 2 below the issue price; Modern Diagnostic listed 10.6% above its issue price.
See the full Modern Diagnostic GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
Same sector or same stage as Modern DiagnosticNo comments yet. Be the first to share your opinion!